Get Tickets Now: The Cancer Summit Series is Coming to Boston, SF, Seattle
We live in a time of tremendous possibility for cancer R&D.
Checkpoint inhibitors, cell therapies, molecular diagnostics that catch cancer early and can guide effective custom treatment – these fields are brimming with progress. All were considered speculative at best a decade ago. The science has never been more promising. Yet pricing and access to this new world of cancer therapy remains thorny. These issues have to be resolved if society is going to reap the benefits of this work.
Come to a Cancer Summit event near you this spring to hear from leading scientists, entrepreneurs, and investors about how they are thinking about the future.
All ticket proceeds go to the Kilimanjaro Climb to Fight Cancer, a philanthropic campaign to support basic cancer research at Fred Hutch.
See the outstanding speakers for each event:
Boston Cancer Summit confirmed speakers:
- David Schenkein, executive chairman, Agios Pharmaceuticals
- Mary Lynne Hedley, co-founder and president, Tesaro
- Cindy Perettie, CEO, Foundation Medicine
- Sanjiv Patel, CEO, Relay Therapeutics
- Garry Menzel, CEO, TCR2 Therapeutics
- Simba Gill, CEO, Evelo Biosciences
- Uciane Scarlett, associate, Atlas Venture
- Katrine Bosley, biotech entrepreneur
- Praveen Tipirneni, CEO, Morphic Therapeutic
- Zoe Barry, CEO, ZappRx
- Phil Rowlands, Head, Oncology Therapeutic Area Unit, Takeda Pharmaceuticals
- Deborah Palestrant, partner, 5AM Ventures; Head, 4:59
- Elliott Sigal, venture partner, NEA
- Leigh Zawel, CSO, small molecules, Cullinan Oncology; executive partner, MPM
- Luke Timmerman, founder and editor, Timmerman Report
SAVE THE DATE: 1-6 pm, April 16, Alexion Pharmaceuticals, 121 Seaport Blvd., Boston
BUY TICKETS HERE
GET TICKETS FOR THE BOSTON CANCER SUMMIT HERE
NOTE: Last year’s events sold out in advance. Buy your tickets early to reserve a seat.
San Francisco Cancer Summit confirmed Speakers:
- Carolyn Bertozzi, Anne T. and Robert M. Bass Professor of Chemistry at Stanford University and Co-Founder, Palleon Pharmaceuticals
- Ira Mellman, vice president, research oncology, Genentech
- Harlan Robins, member, Fred Hutch; program head, computational biology; co-founder, Adaptive Biotechnologies
- Stanley Riddell, member, Fred Hutch; scientific director, Immunotherapy Integrated Research Center; co-founder, Juno Therapeutics
- Bonnie Anderson, co-founder and CEO, Veracyte
- Nina Kjellson, general partner, Canaan Partners
- Ben Hindson, co-founder and CSO, 10X Genomics
- Larry Corey, past president of Fred Hutch, co-PI of the HIV Vaccine Trials Network
- Lesley Stolz, head, JLABS Bay Area
- Bill Newell, CEO, Sutro Biopharma
- Omid Farokhzad, CEO, Seer
- Angie You, CEO, Amunix Pharmaceuticals
- Steve James, CEO, Pionyr Immunotherapeutics
- Bassil Dahiyat, CEO, Xencor
- Luke Timmerman, founder and editor, Timmerman Report
SAVE THE DATE: 1-6 pm, April 18, Biocom Bay Area, 1 Tower Place, South San Francisco
GET TICKETS FOR THE SAN FRANCISCO CANCER SUMMIT HERE
NOTE: Last year’s events sold out in advance. Buy your tickets early to reserve a seat.
Seattle Cancer Summit confirmed speakers:
- Gary Gilliland, president and director, Fred Hutch
- Chad Robins, co-founder and CEO, Adaptive Biotechnologies
- Steve Harr, co-founder and CEO, Sana Biotechnology
- Charlotte Hubbert, partner, Gates Foundation Venture Capital
- Peter Thompson, private equity partner, OrbiMed; co-founder, Silverback Therapeutics
- Sam Blackman, founder and chief medical officer, Day One Therapeutics
- Heidi Hagen, co-founder and chief strategy officer, Vineti
- Bob More, partner, Alta Partners
- Thong Le, CEO, Accelerator Life Science Partners
- Clayton Knox, chief operating officer, Mavupharma
- Kristin Anderson, postdoctoral fellow, Fred Hutch Phil Greenberg Lab, Society for Immunotherapy of Cancer Presidential Award-winning young investigator
- Racquel Bracken, vice president, Venrock
- Brad Gray, CEO, NanoString Technologies
- Tom Daniel, venture partner, ARCH Venture Partners
- Kelly O’Brien, vice president of philanthropy, Fred Hutch
- Mark Litton, president and COO, Alpine Immune Sciences
- Luke Timmerman, founder and editor, Timmerman Report
SAVE THE DATE: 1-5:30 pm, May 10, Fred Hutch, Pelton Auditorium, Seattle
GET TICKETS FOR THE SEATTLE CANCER SUMMIT HERE
NOTE: Last year’s events sold out in advance. Buy your tickets early to reserve a seat.
You may also like
